Expression of hepatitis C virus NS5A natural mutants in a hepatocytic cell line inhibits the antiviral effect of interferon in a PKR-independent manner

Hepatology

Volumn 33, Issue 6, 2001, Pages 1503-1511

  Podevin, Philippe ^a   Sabile, Abdelmajid ^a   Gajardo, Rodrigo ^a   Delhem, Nadira ^a   Abadie, Annie ^b   Lozach, Pierre Yves ^a   Beretta, Laura ^b,c   Bréchot, Christian ^a  

^a INSERM   (France)

^b INSTITUT CURIE   (France)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; DOUBLE STRANDED RNA; DOUBLE STRANDED RNA DEPENDENT KINASE; PROTEIN KINASE; PRTOEIN NS5A; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENCEPHALOMYOCARDITIS VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; VESICULAR STOMATITIS VIRUS; VIRUS EXPRESSION; VIRUS MUTATION;

EID: 0034992398     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.24749     Document Type: Article

References (39)

1. Hepatitis C virus biology and genetic variability: Implications for the management of infected patients
2. Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions
3. Expression and identification of hepatitis C virus polyprotein
4. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome
5. Epidemiology of hepatitis C
6. Hepatitis C and hepatocellular carcinoma
7. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional therapy group
8. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C
9. Interferon-ribavirin for chronic hepatitis C with or without cirrhosis: Analysis of individual patient data of six controlled trials. Eurohep study group for viral hepatitis
10. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanism of kinase regulation
11. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon-sensitive virus replication
12. Expression of Hepatitis C Virus proteins inhibits signal transduction through the Jak-STAT pathway
13. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region
14. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection
15. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b
16. Mutations in hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon alfa therapy in French patients
17. Interferon resistance of hepatitis C virus genotype 1b: Relationship to nonstructural 5A gene quasispecies mutations
18. The "interferon sensitivity determining region" of hepatitis C virus is a stable sequence element
19. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alfa
20. Long-term response to interferon alpha is unrelated to "interferon sensitivity determining region" variability in patients with chronic hepatitis C virus-1b infection
21. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa
22. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity
23. The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon
24. Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: A new role for an old actor
25. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein
26. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase
27. Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth
28. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein
29. The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast
30. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in an src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling
31. Nonstructural protein 5A of hepatitis C virus inhibits the function of karyopherin 3
32. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A non-B hepatitis
33. Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologue
34. Continous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins
35. The interferon-induced double-stranded RNA-activated protein kinase PKR will phosphorylate serine, threonine, or tyrosine at residue 51 in eukaryotic initiation factor 2 alpha
36. Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with the clinical response
37. Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis
38. Efficient initiation of HCV RNA replication in cell culture
39. A novel mechanism of hepatitis C virus interferon resistance: Induction of expression of the CXC chemokine, interleukine-8, by the non-structural 5A protein